January 23, 2019
TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has appointed Dr. Joseph Sparano as lead of its Breast Cancer Program Scientific Advisory Board (SAB). Dr. Joseph Sparano is Professor of Medicine & Women's Health at the Albert Einstein College of Medicine, Associate Chairman for Clinical Research in the Department of [...]
ZEISS introduces next generation X-ray microscopes
January 23, 2019
ZEISS Xradia 600-series Versa enables faster submicron-resolution imaging of intact samples JENA/Germany. ZEISS introduces two new advanced models of the ZEISS Xradia Versa family: The ZEISS Xradia 610 & 620 Versa X-ray microscopes excel through faster non-destructive imaging of intact samples without sacrificing resolution and contrast over the full range of power and kV. Leading [...]
January 23, 2019
-- Expands Potential Serviceable Market to Include Companies Requiring Certification -- SAN FRANCISCO--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that its quality management systems for manufacturing its next-generation sequencing (NGS) Target Enrichment Panels received International Organization for Standardization(ISO) 9001:2015 and 13485:2016 certification1, the latter [...]
New Leica imagers set to transform visualization of 3D samples
January 23, 2019
THUNDER imager family enables users to decode 3D biology in real-time* Wetzlar. World-leading designer and manufacturer of innovative microscope solutions, Leica Microsystems, has announced the launch of a new class of instruments for high-speed, high-quality imaging of a large diversity of samples, including thick specimens. THUNDER Imagers allow to visualize clearly in real time details [...]
January 23, 2019
ANCOUVER, BRITISH COLUMBIA – STEMCELL Technologies has released mTeSR™ Plus, an enhanced version of mTeSR™1, the most widely published feeder-free human pluripotent stem cell (hPSC) maintenance medium. The new medium has undergone successful beta testing with several members of the Stem Cell COREdinates group and has completed rigorous in-house validation testing. Designed to promote a more consistent [...]
Schrödinger Appoints Veteran Biotech Industry Leader Dr. Rosana Kapeller to Board of Directors
January 23, 2019
NEW YORK – Schrödinger, a privately held company revolutionizing drug discovery and materials design through advanced molecular simulations, today announced the appointment of veteran biotech leader Rosana Kapeller, M.D., Ph.D., to its board of directors. “I am delighted and honored to join Schrödinger during such a pivotal time in the company’s growth,” said Dr. Kapeller. [...]
Oxford Nanopore prevails in patent ruling against Pacific Biosciences
January 22, 2019
Today the European Patent Office revoked Pacific Biosciences patent EP3045542 with claims to a single molecule sequencing process wherein two strands of DNA are linked by a connecting nucleic acid. The validity of the patent had been challenged by Oxford Nanopore. The EPO ruled that the claims to a single molecule sequencing process were unsupported [...]
January 22, 2019
Scilligence Joins Accenture’s Life Sciences Research Platform Ecosystem to Help Drive Innovation in Drug Discovery and Scientific Research BOSTON: Scilligence, a provider of mobile cheminformatics and bioinformatics for the life sciences industry, has joined the Accenture research platform open partner ecosystem, which will allow for the integration of Scilligence’s informatics solutions. Scilligence’s proprietary technologies address three [...]
NEWS & EVENTS HARBOUR BIOMED INTEGRATES THE BEACON® PLATFORM TO ACCELERATE ANTIBODY DISCOVERY
January 22, 2019
Berkeley Lights Further Extends into Asian Market Emeryville, Calif., Cambridge, Mass, Shanghai, China– Berkeley Lights, Inc. (BLI), the leader in digital cell biology, announced today that Harbour BioMed, a global biopharmaceutical company has acquired the Beacon® Optofluidic platform to implement accelerated workflows for single-cell screening and analysis. “Harbour BioMed is pleased to integrate the Berkeley Lights Beacon platform [...]
The FDA Grants Breakthrough Device Designation for Illumina’s TruSight Assay
January 22, 2019
Based on the content of TruSight Oncology 500, the proposed in vitro diagnostic will receive prioritized review and resources Today, Illumina announces that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for its pan-cancer assay. Currently in development, with plans to be marketed as TruSight™ Oncology Comprehensive, the assay is based on [...]

